WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007007162) NEW COMBINATION OF ANTI-MADCAM ANTIBODY AND ANTIFIBROTIC CASPASE INHIBITOR TO TREAT LIVER FIBROSIS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/007162    International Application No.:    PCT/IB2006/001896
Publication Date: 18.01.2007 International Filing Date: 03.07.2006
IPC:
A61K 39/395 (2006.01), A61K 31/16 (2006.01), A61K 31/33 (2006.01), A61P 29/00 (2006.01)
Applicants: PFIZER LIMITED [GB/GB]; Ramsgate Road, Sandwich, Kent CT13 9NJ (GB) (For All Designated States Except US).
BURGESS, Gary, Craig [ZA/GB]; (GB) (For US Only).
KERRY, Roger [GB/GB]; (GB) (For US Only)
Inventors: BURGESS, Gary, Craig; (GB).
KERRY, Roger; (GB)
Agent: DROUIN, Stephane; Pfizer Global Research and Development, Ramsgate Road, Sandwich, Kent CT13 9NJ (GB)
Priority Data:
60/698,561 11.07.2005 US
Title (EN) NEW COMBINATION OF ANTI-MADCAM ANTIBODY AND ANTIFIBROTIC CASPASE INHIBITOR TO TREAT LIVER FIBROSIS
(FR) NOUVELLE COMBINAISON D'UN ANTICORPS ANTI-MADCAM ET D'UN INHIBITEUR DE CASPASE ANTI-FIBROTIQUE POUR LE TRAITEMENT DE LA FIBROSE DU FOIE
Abstract: front page image
(EN)The invention relates to a new combination of an anti-MAdCAM antibody with an anti-fibrotic agent, such as a protease inhibitor, preferably a caspase inhibitor. The invention also relates to pharmaceutical compositions comprising the combination of the invention, and the use of the combination for the treatment of liver fibrosis.
(FR)L'invention concerne une nouvelle combinaison d'un anticorps anti-MAdCAM et d'un agent anti-fibrotique, tel qu'un inhibiteur de protéase, de préférence un inhibiteur de caspase. L'invention concerne également des compositions pharmaceutiques comprenant la combinaison susmentionnée ainsi que l'utilisation de cette combinaison pour le traitement de la fibrose du foie.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)